Background Since 2014, the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has produced an annual report of all bariatric surgery submitted to the Global Registry. We describe baseline demographics of international practice from the 4th report. Methods The IFSO Global Registry amalgamated data from 51 different countries, 14 of which provided data from their national registries. Data were available from 394,431 individual records, of which 190,177 were primary operations performed since 2014. Results Data were submitted on 72,645 Roux en Y gastric bypass operations (38.2%), 87,467 sleeve gastrectomy operations (46.0%), 14,516 one anastomosis gastric bypass procedures (7.6%) and 9534 gastric banding operations (5.0%) as the primary operation since 2014. The median patient body mass index (BMI) pre-surgery was 41.7 kg m 2 (inter-quartile range: 38.3-46.1 kg m 2 ). Following gastric bypass, 84.1% of patients were discharged within 2 days of surgery; and 84.5% of sleeve gastrectomy patients were discharged within 3 days. Assessing operations performed between 2012 and 2016, at one year after surgery, the mean recorded percentage weight loss was 28.9% and 66.1% of those taking medication for type 2 diabetes were recorded as not using them. The proportion of patients no longer receiving treatment for diabetes was highly dependent on weight loss achieved. There was marked variation in access and practice. Conclusions A global description of patients undergoing bariatric surgery is emerging. Future iterations of the registry have the potential to describe the operated patients comprehensively.
Introduction
With international prevalence increasing year on year, and corresponding increases in the burden of related disease, it is clear that obesity is a problem that has to be addressed [1, 2] . Although bariatric surgery has been demonstrated to be a safe, effective and sustainable method of weight loss with associated reduction of obesity-related disease [3, 4] , it is only performed on a very small percentage of patients who could benefit from it [5] .
Bariatric surgery has the potential to improve health, in a costeffective manner, to a large number of patients. However, accessibility to surgery varies within and between countries. Some information has been gleaned by worldwide surveys of practice of bariatric surgeons, but overall, little is still known about the demographics and trends of patients being operated on around the world [6] [7] [8] [9] [10] [11] . Thus, although the surveys demonstrate the different kinds of operations and changes in practice over time in different regions, data on patient-related factors such as age, gender, body mass index (BMI) and obesity-related disease, for example type 2 diabetes and hypertension, are lacking. In addition, there is limited information on variation in surgical outcomes including length-of-stay or reduction in BMI or effect on obesity-related diseases on a national or international basis.
In an effort to answer some of these questions, the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) developed a Global Registry, in association with a software and analysis provider, Dendrite Clinical Systems Ltd., aiming to create a global estimate of bariatric surgery practice. The Global Registry has reported on its findings for the last 4 years [12] [13] [14] [15] . In this 4th report, the number of individual patient records has doubled the information available compared to the third report, together with a near doubling in the number of national registries submitting data [14, 15] . In this paper, we summarise the findings of the 4th international analysis of outcomes from bariatric and metabolic surgery.
Methods
National societies were invited by the IFSO President Dr. Jacques Himpens to participate in the Global Registry as previously detailed [16] and a 4th report was commissioned for distribution at the IFSO World Congress in Dubai 2018 [15] . Descriptive statistics were used for the analysis of the data. The contributors were reassured that no statistical comparison would be attempted between different units or countries. Data presented in graphs define the number of "valid" records, indicating the number of records where obesity-related disease National registries denoted in italics a Number of centres not provided at the time of submission could be ascertained and cases with "no data", the number of cases unavailable for subgroup analysis. The dataset, defined by a committee for the 1st report, has since been extended slightly, for instance to include explicitly one anastomosis gastric bypass as a procedure distinct from Roux en Y bypass. The dataset for the current version 4.1 is shown (Table 1 ) [16] . All operations entered up until 4th July 2018 were included in the analysis. All data presented are in relation to primary procedures. Operative data are presented from 2014 to 2018; follow-up data are presented from 2012 to 2016 to account for the inevitable lag in data capture.
Results
The registry contained 394,431 individual operation records at the time of last data submission. Numbers of participating countries, national registries, individual centres and submitted cases have steadily increased year on year ( Table 2 ). The number of records submitted ranged greatly from 10 from a single centre to over 80,000 submitted by the Italian national registry (Table 3) . We do not have complete country-data on case ascertainment.
The majority of the database records fell in the period 2009-2018 (88.5% of the total) although some countries have submitted data from procedures prior to 2000; 190,177 of primary operations were dated in the calendar years 2014-2018. Forty-six percent of the baseline records were > 80% complete in data submitted in the calendar years 2014-2018. Variation in data completion for the whole registry is presented (Table 4) .
Patient Demographics
The following baseline analyses relate to primary operations in the calendar years 2014-2018. The overall proportion of female patients was 73.7% (95% CI: 73.5-73.9%). Although operations were more common in females in all countries, there was also a wide variation in the gender ratios, ranging from 50.9% female in Georgia (55/108) to 93.4% female in Guadeloupe (183/196). For the 16 countries with ≥ 1000 submitted patients, the gender ratios were 57.7% female (India; n = 11,088) to 79.4% female (Netherlands; n = 37,818).
The median BMI pre-surgery was 41.7 kg m 2 (interquartile range: 38.3-46.1 kg m 2 ); there was a wide variation between different contributor countries, with medians ranging from 34.2 kg m 2 in South Korea to 49.1 kg m 2 in Germany (Fig. 1a) . The median age at time of operation was 42 years (inter-quartile range: 33-51 years; Fig. 1b ) There was variation between countries with a trend to Middle Eastern and Asian countries having a younger, or adolescent practice, with those in the West more commonly operating at an older age. For the 16 countries with ≥ 1000 submitted patients, the BMI range was 37.3 (China; n = 1939) to 44.5 (Saudi Arabia; n = 2119).
Obesity-Related Disease Prior to Surgery
As expected, a large proportion of patients had obesity-related disease. There was large variation in the reported rates of these conditions between countries. Overall, those on medication for type 2 diabetes made up 19.8% of patients (inter-country variation: 4.5-97.7%); 30.6% were treated for hypertension (10.9-92.6%) and 12.4% of patients were on medication for depression (0.0-54.4%). Also, 24.3% of patients reported requiring treatment for musculoskeletal pain (0.0-65.1%); 18.6% of patients had diagnosed sleep apnea (0.0-74.3%); and 17.0% of patients had gastro-esophageal reflux disease (0.0-54.8%). Amongst those countries with ≥ 1000 submitted patients, the respective figures were 19.5% (9.8-43.5%) for type 2 diabetes, 30.2% (15.5-46.3%) for hypertension, 12.5% (0.6-29.1%) for depression, 24.6% (0.0-50.4%) for musculoskeletal pain, 18.4% (0.0-36.8%) for sleep apnea and 17.0% (6.4-40.7%) for GERD. The variation in disease prevalence between regions is shown (Fig. 2a, b) . Fig. 4 and Table 5 .
Length of Stay
The vast majority of patients who had a gastric band inserted were discharged within 1 day of their operation (88.5%); gastric bypass patients within 2 days of surgery (84.1%); and sleeve gastrectomy patients within 3 days (84.5%). This 
One-Year Follow Up
For the 184,871 primary operations recorded between 2012 and 2016, 116,431 had follow-up records (63.0%). One-year follow-up was more complete in those patients having Roux en Y gastric bypass than sleeve gastrectomy (57.4% vs 29.4%). Variation in attainment of follow-up data for the Roux en Y gastric bypass group is shown (Table 6) .
Over all types of surgery, the average recorded percentage weight loss was 28.9% a year after surgery: 30.0% for Roux en Y; 29.1% for gastric sleeve; 16.1% for gastric band; and 32.9% for one anastomosis gastric bypass. As would be expected, the percentage weight loss at 1 year was greater in those with a higher initial BMI (Fig. 6a) .
One year after primary surgery, 66.1% of those taking medication for type 2 diabetes beforehand were no longer on medication; the proportion of patients no longer treated for diabetes was highly dependent on weight loss achieved, with the rate of improvement increasing with higher percentage weight loss (Fig. 6b) .
Discussion
This dataset derived from the continuing IFSO Global Registry gives an extensive and unique overview of practice in bariatric surgery, demonstrating variations in patient and operation selection in different countries. If the datasets submitted by national registries have accurate case ascertainment, then it is likely that they represent Fig. 2 (continued) accurately the practice in each country. However, the IFSO Global Registry has no mechanism to check case ascertainment, submission of incomplete or erroneous data, and it is assumed that each submitting society provides this validation. The same assumption is made for all individual hospital submissions. Future iterations of the dataset could include a question about whether the data have been validated before submission. However, even in small datasets, the data submitted appear consistent with known parameters in that country: the number of patients submitted from Germany in this report is only 22 but their median BMI is similar to that of the known caseload in that country [18] .
To enable high levels of participation and compliance with the Global Registry, the dataset has purposefully been kept short and minimal, predominantly in the form of 'Yes/No' questions. However, the simplicity of the data collected may miss important outcomes, and it is not in line with recommendations on standardised bariatric surgery outcomes reporting [19] . There is a fine balance between the two approaches to achieve a comprehensive, detailed database with true case attainment: there is more work to be done to achieve the perfect equilibrium.
We noted that the overall completion of the baseline dataset was 63%. Differences in how registries are set [20] . Qualitative assurance and improvement projects might be a future goal of the IFSO Global Registry. However, thus far, the project has been limited to a description of baseline demographics and 1-year outcomes so as to encourage continuing data submission and recognising the inherent challenges of data validation as described above. In the future, standardising a minimum bariatric dataset could be a goal for national registries and local databases worldwide.
Although this year, the number of national registries submitting data has increased to 14, there are still large areas of the world whose data are unknown. Other countries have large comprehensive registries: in the USA, the MBSAQIP (Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program) is a large collaboration between the American College of Surgeon and the ASMBS (American Society for Metabolic and Bariatric Surgery) and the resulting Participant Use Data File (PUF) is released periodically for independent analysis by participating centres. Recent reports from the 2015 PUF provide baseline demographic descriptions that are complementary to the data presented here [21] [22] [23] . Many countries have data submitted from only a single centre, which means that this may only reflect local practice rather than national trends. Continued efforts to recruit new centres and obtaining data from existing, and developing, national Data from Central America and Australasia excluded due to small numbers OAGB/MBG one anastomosis gastric bypass/mini-gastric bypass registries will strengthen the description of baseline demographics in patients operated worldwide. The data collected via the Global Registry mirror the operative trends of the 2016 international survey of practice [11] . The international survey obtains a wider coverage of complete countries than is obtained by the Global Registry; however, where no national registry is available, these numbers may be estimated. In addition, the Global Registry collects a greater depth of data, with patient variables and outcome data within the limitation of the dataset. The estimated international number of operations performed in 2016 was 634,897. This suggests at this time around 7.5% of all international operations are being logged on the global registry, an increase from previous years [16] .
Even though the overall attainment of 1-year follow-up data has increased, weight loss and diabetes status are the only variables retrieved with sufficient frequency to allow meaningful comparison, with 32.5% and 23.3% of cases with follow-up, respectively. [16] We note the differences in captured follow-up for patients with diabetes having gastric bypass (41.1%) and sleeve gastrectomy (11.9%). The reasons for this are unknown, but might be due to different follow-up data submitted by the geographically separate centres doing these operations. Also, the data presented in the full 4th report show some promising trends in improvement of hypertension, sleep apnea, depression, and musculoskeletal pain, but with follow-up records available for fewer than 10% of cases, no conclusions can be drawn from these findings [15] . A challenge for this and all registries is how to achieve better follow-up data.
One of the benefits of such a registry enables us in real time to appreciate the changes in practice, initially with the rise in popularity of the sleeve gastrectomy, and now with an emerging increase in the number of one anastomosis gastric bypass operations being performed. Such understanding can help us focus our research questions to make them relevant, as demonstrated by the By-Band study which evolved to become the By-Band-Sleeve randomised controlled trial in the UK, as the number of sleeve gastrectomies performed increased. [24] Limitations of the paper include lack of generalizability due to incomplete case ascertainment, and inability to assess incomplete or erroneous data submission, as well as incomplete follow-up data. In addition to the limitations of the Yes/No questions, there is unknown selection bias for those patients with recorded follow-up. Swedish, Norwegian and Dutch surgeons have shown that it is possible to amalgamate large datasets with the aim of demonstrating differences in mortality and complication rates between different countries. [20] Over time, future iterations of the IFSO Global Registry might be able to achieve this on a much wider scale. If this became possible, the bariatric community would be able to demonstrate further the safety of bariatric/metabolic surgery on a generalizable basis.
In summary, there is a wide variation in bariatric practice internationally with sleeve gastrectomy now the most commonly performed bariatric procedure. The burden of obesityrelated disease in the operated populations is high but varies greatly between regions. Worldwide, bariatric surgery provides marked weight loss and remission of diabetes at 1 year. Further data are needed to show the effect on other obesityrelated diseases. 
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